Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 6 Lung Neoplasms 2 Colonic Polyps 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Precancerous Conditions 1 Melanoma 1 Disease 1

Interventions

Ipilimumab 114 pembrolizumab 95 Nivolumab 91 aldesleukin 86 Interleukin-2 57 Cyclophosphamide 54 Dacarbazine 52 Vemurafenib 39 trametinib 37 Temozolomide 37 incomplete Freund's adjuvant 35 fludarabine phosphate 35 sargramostim 32 dabrafenib 32 fludarabine 26 Bevacizumab 26 Paclitaxel 22 MART-1 Antigen 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 montanide ISA 51 20 Interferon-alpha 20 Cisplatin 20 Carboplatin 19 Sorafenib 18 Introns 17 Biopsy 17 cobimetinib 16 Radiosurgery 16 atezolizumab 15 Radiotherapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Diagnosis, Computer-Assisted × Clear all

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

105 enrolled 15 charts

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡